Response to Scottish Government decision to fund Orkambi and next steps in England
Last month the independent Scottish Medicines Consortium assessed that Vertex’s ‘justification of the treatment’s [Orkambi and Symkevi] costs in relation to its health benefits was not sufficient’: meaning the company was charging an unreasonably high price for its product.
Vertex has rejected the health service’s offer, which would give access to the treatment for people with cystic fibrosis (CF), at a price assessed as appropriate for the clinical effectiveness of the medicine. It was the largest offer the NHS has ever made for a treatment of its kind.
Therefore it is regrettable that Vertex continues to choose not to engage with the National Institute for Health and Care Excellence (NICE) but invests energy into political lobbying instead.
This is clearly disappointing and we continue to work with the company on how we can make its treatments available.
Across the globe, we know that many other countries have had similar experiences.
Sadly Vertex remains an extreme outlier in its monopoly pricing, which is why a number of countries – including for example Switzerland, New Zealand, Belgium and Spain – have also been unable to get Vertex to make Orkambi available to their patients.
Decisions on funding for treatments are always difficult and complex which is why there is a longstanding, world-leading and tried and tested approach – led by clinicians and not politicians – to establish the clinical effectiveness and value for money offered by proposed treatments.
The NHS cannot offer a blank cheque to an individual company at the expense of our ability to provide a wide range of treatments to as many people as possible.
Over the past year working with a wide variety of responsible pharmaceutical companies the NHS in England has secured life-saving, life-changing drugs for patients, including new treatments for haemophilia, rare cancers, multiple sclerosis, muscle-wasting in children and, just this week, Batten Disease.
We want to reassure patients in England that in the absence of Vertex accepting a reasonable, fair and generous offer, the NHS continues to look at, and design, viable alternative solutions to bringing treatments to cystic fibrosis sufferers.
Latest News from
NHS staff morale improves but too many facing abuse19/02/2020 09:15:00
NHS staff say they are now happier and more likely to recommend their organisation as a place to work than last year, but too many still experience unacceptable abuse from patients and the public.
First patients begin gene therapy treatment for blindness as part of NHS Long Term Plan18/02/2020 11:11:00
The first patients have received a revolutionary new gene therapy that can restore eyesight as part of the NHS Long Term Plan.
NHS England and NHS Improvement Coronavirus Update17/02/2020 13:15:00
The last of the guests staying at Arrowe Park after returning from China have left the hospital, NHS England and NHS Improvement announced recently (15 February 2020).
NHS publishes new workforce race equality data, ahead of NHS and race summit14/02/2020 11:05:00
Every NHS trust in London now has at least one black and minority ethnic (BME) board member, according to new data published yesterday.
Chief Nursing Officer appoints first-ever adviser for care home nursing12/02/2020 14:15:00
England’s most senior nurse has appointed the lead on health and wellbeing for Chelsea Pensioners as her advisor on improving support for care home nurses.
NHS Long Term Plan to boost nurse apprenticeships11/02/2020 09:15:00
England’s most senior nurse has called on NHS organisations to boost the number of nursing apprenticeships they offer to local people, to help deliver the health service’s Long Term Plan to improve patient care.
Statement from NHS England and NHS Improvement on Coronavirus10/02/2020 14:15:00
The director of the NHS’ response to the coronavirus outbreak has reminded people concerned about infection to call NHS 111 for advice.
Update on gender identity development service for children and young people31/01/2020 14:15:00
The NHS updates nationally commissioned services every few years. In 2016 NHS England put in place a new service specification for gender identity development services for children and young people and committed to conducting a review of this specification and associated policies for 2020.
Greener NHS campaign to tackle climate ‘health emergency’28/01/2020 09:15:00
NHS Chief Sir Simon Stevens recently (25 January 2020) announced the NHS and its staff will step up action to tackle the climate “health emergency” this year, helping prevent illness, reducing pressure on A&Es, and saving tens of thousands of lives.